Jason L. Weirather
- Molecular Biology
- Oncology top 5%
- Immunology top 5%
- Public Health, Environmental and Occupational Health top 5%
- Epidemiology
- Co-authors
- Scott J. RodigKin Fai AuMary E. WilsonF. Stephen HodiAnita Giobbie‐HurderShyam SundarAnna C. PavlickChristine E. Horak
- Topics
- Cancer Immunotherapy and Biomarkers (13 papers)CAR-T cell therapy research (5 papers)Research on Leishmaniasis Studies (5 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesBrazilUnited Kingdom
In The Last Decade
Jason L. Weirather
33 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 634
- Oncology 600
- Immunology 466
- Public Health, Environmental and Occupational Health 274
- Epidemiology 199
Countries citing papers authored by Jason L. Weirather
This map shows the geographic impact of Jason L. Weirather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason L. Weirather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason L. Weirather more than expected).
Fields of papers citing papers by Jason L. Weirather
This network shows the impact of papers produced by Jason L. Weirather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason L. Weirather. The network helps show where Jason L. Weirather may publish in the future.
Co-authorship network of co-authors of Jason L. Weirather
This figure shows the co-authorship network connecting the top 25 collaborators of Jason L. Weirather. A scholar is included among the top collaborators of Jason L. Weirather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason L. Weirather. Jason L. Weirather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 17 | |
| 3 | 16 | |
| 4 | 19 | |
| 5 | 13 | |
| 6 | 14 | |
| 7 | 1 | |
| 8 | 88 | |
| 9 | 8 | |
| 10 | 28 | |
| 11 | MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanomabreakdown → | 408 |
| 12 | 16 | |
| 13 | 5 | |
| 14 | 18 | |
| 15 | 80 | |
| 16 | 5 | |
| 17 | 43 | |
| 18 | 98 | |
| 19 | 10 | |
| 20 | 10 |
About Jason L. Weirather
Jason L. Weirather is a scholar working on Oncology, Internal Medicine and Immunology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (5 papers) and Research on Leishmaniasis Studies (5 papers). The work is most often cited by research in Immunology (466 citations), Oncology (600 citations) and Cancer Research (172 citations). Jason L. Weirather has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Scott J. Rodig, Kin Fai Au, Mary E. Wilson, F. Stephen Hodi, Anita Giobbie‐Hurder, Shyam Sundar, Anna C. Pavlick, Christine E. Horak, Donald Jackson and Han Chang. Their work appears in journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.